샘플 요청 목록

 카트 문의
시장보고서
상품코드
1775001

세계의 포유류 세포 발효 기술 시장

Mammalian Cell Fermentation Technology
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 392 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 포유류 세포 발효 기술 시장은 2030년까지 707억 달러에 이를 전망

2024년에 452억 달러로 추정되는 포유류 세포 발효 기술 세계 시장은 2024-2030년간 CAGR 7.7%로 성장하여 2030년에는 707억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 중국 햄스터 난소 세포 발효는 CAGR 9.7%를 나타내고, 분석 기간 종료까지 326억 달러에 이를 것으로 예측됩니다. 인간 배성 신장 세포 발효 분야의 성장률은 분석 기간중 CAGR 5.3%로 추정됩니다.

미국 시장은 123억 달러로 추정, 중국은 CAGR 12.4%를 보일 것으로 예측

미국의 포유류 세포 발효 기술 시장은 2024년에 123억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 153억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.7%와 7.5%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.2%로 성장할 전망입니다.

세계의 포유류 세포 발효 기술 시장 - 주요 동향과 촉진요인 정리

포유류 세포 발효 기술의 중요성이 커지는 이유는 무엇일까?

포유류 세포 발효 기술은 치료용 단백질, 단클론 항체, 백신, 유전자 치료 제품의 대량 생산을 가능하게 하는 바이오 제약 산업에서 중요한 구성 요소입니다. 박테리아나 효모 기반 발효와 달리 포유류 세포 시스템은 복잡한 번역 후 변형이 가능하여 생물학적으로 활성적이고 인간에 적합한 단백질을 생산하는 데 필수적입니다. 생물학적 제제, 맞춤의료, 재생치료에 대한 수요가 지속적으로 증가함에 따라 첨단 포유류 세포 발효 기술의 채택이 확대되고 있습니다.

암, 자가면역질환, 희귀유전질환과 같은 만성질환의 유병률 증가는 바이오의약품 연구개발에 대한 투자를 촉진하고 있습니다. 제약사 및 위탁생산 기관은 의약품 개발을 가속화하고 생산 효율성을 높이며 엄격한 규제 기준을 충족하기 위해 포유류 세포 배양 시스템을 활용하고 있습니다.

기술 혁신은 포유류 세포 발효 기술의 성능을 어떻게 향상시키고 있는가?

일회용 바이오리액터, 연속 생산 시스템, 인공지능을 통한 공정 최적화의 발전은 포유류 세포 발효에 혁명을 불러일으키고 있습니다. 일회용 시스템은 오염 위험을 줄이고, 운영 비용을 낮추며, 확장성을 향상시키기 때문에 바이오 의약품 제조업체에게 선호되는 선택이 되고 있습니다. 또한, 유전자 편집 기술 및 합성 생물학의 발전으로 세포주 공학이 강화되어 보다 빠르고 효율적인 단백질 발현이 가능해졌습니다.

자동화와 데이터 분석은 발효 조건을 최적화하고, 변동을 최소화하며, 일관된 제품 품질을 보장하는 데 중요한 역할을 하고 있습니다. 인공지능과 머신러닝 알고리즘은 실시간 모니터링 시스템에 통합되고 있으며, 수율과 효율성을 극대화하기 위해 예측 유지 보수 및 적응형 공정 제어를 가능하게 하고 있습니다.

주요 시장 성장 촉진요인은?

생물학적 제제, 유전자 치료제, 세포 기반 백신에 대한 수요 증가는 포유류 세포 발효 시장의 주요 촉진요인입니다. 정부 및 규제 기관은 신속한 승인과 팬데믹 대응을 위한 자금 지원을 통해 생물학적 제제 제조의 확대를 지원하고 있습니다. 바이오시밀러와 차세대 항체 치료제의 부상도 비용 효율적이고 확장 가능한 포유류 세포 배양 기술의 필요성을 촉진하고 있습니다.

또한, 개인 맞춤형 의료의 발전으로 환자 개개인에 맞는 맞춤형 세포주에 대한 수요가 증가하고 있습니다. 제약회사들이 비용 절감과 제품화 시간 단축을 위해 포유류 세포 발효를 전문 업체에 위탁함에 따라 위탁 개발 및 제조 기관 부문은 괄목할 만한 성장세를 보이고 있습니다. 바이오 제조의 지속가능성에 대한 관심이 높아지면서 친환경 세포 배양 배지 및 에너지 효율이 높은 발효 기술이 채택되고 있습니다.

어떤 과제와 미래 기회가 존재할까?

포유류 세포 발효의 과제는 높은 생산 비용, 복잡한 규제 요건, 기존 배치 공정의 확장성 한계 등을 들 수 있습니다. 세포의 생존성을 유지하고 증식 조건을 최적화하는 것은 여전히 중요한 기술적 장애물입니다. 그러나 연속관류 바이오리액터, 인공지능을 통한 세포 배양 최적화, 하이브리드 발효 모델과 같은 새로운 기술 혁신은 비용 효율적이고 수율이 높은 바이오의약품 생산의 새로운 기회를 열어주고 있습니다.

개인 맞춤형 세포치료, 인공지능 기반 공정 자동화, 모듈형 바이오 제조 시설의 채택이 증가하고 있으며, 포유류 세포 발효 기술의 미래를 형성할 것으로 예측됩니다.

부문

유형(중국 햄스터 난소 세포 발효, 인간 배성 신장 세포 발효, 베이비 햄스터 신장 세포 발효, 마우스 골수종 세포 발효, 기타 유형), 용도(단일클론항체 용도, 재조합 단백질 용도, 백신 용도, 호르몬 용도, 효소 용도, 기타 용도), 최종 용도(바이오의약품 기업 최종 용도, 학술기관 및 연구기관 최종 용도, 기타 최종 용도)

조사 대상 기업 예

  • AGC Biologics
  • Amgen Inc.
  • AstraZeneca plc
  • Becton, Dickinson and Company(BD)
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Moderna, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Samsung Biologics
  • Sartorius AG
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.31

Global Mammalian Cell Fermentation Technology Market to Reach US$70.7 Billion by 2030

The global market for Mammalian Cell Fermentation Technology estimated at US$45.2 Billion in the year 2024, is expected to reach US$70.7 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Chinese Hamster Ovary Cell Fermentation, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$32.6 Billion by the end of the analysis period. Growth in the Human Embryonic Kidney Cell Fermentation segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.3 Billion While China is Forecast to Grow at 12.4% CAGR

The Mammalian Cell Fermentation Technology market in the U.S. is estimated at US$12.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.3 Billion by the year 2030 trailing a CAGR of 12.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Mammalian Cell Fermentation Technology Market - Key Trends & Drivers Summarized

Why Is Mammalian Cell Fermentation Technology Gaining Importance?

Mammalian cell fermentation technology is a critical component in the biopharmaceutical industry, enabling the large-scale production of therapeutic proteins, monoclonal antibodies, vaccines, and gene therapy products. Unlike bacterial or yeast-based fermentation, mammalian cell systems allow for complex post-translational modifications, making them essential for producing biologically active and human-compatible proteins. As the demand for biologics, personalized medicine, and regenerative therapies continues to rise, the adoption of advanced mammalian cell fermentation technology is expanding.

The increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and rare genetic conditions is driving investments in biopharmaceutical research and development. Pharmaceutical companies and contract manufacturing organizations are leveraging mammalian cell culture systems to accelerate drug development, enhance production efficiency, and meet stringent regulatory standards.

How Are Innovations Enhancing the Performance of Mammalian Cell Fermentation Technology?

Advancements in single-use bioreactors, continuous manufacturing systems, and artificial intelligence-driven process optimization are revolutionizing mammalian cell fermentation. Single-use systems reduce contamination risks, lower operational costs, and improve scalability, making them a preferred choice for biopharmaceutical manufacturers. Additionally, developments in gene-editing techniques and synthetic biology are enhancing cell line engineering, enabling faster and more efficient protein expression.

Automation and data analytics are playing a significant role in optimizing fermentation conditions, minimizing variability, and ensuring consistent product quality. Artificial intelligence and machine learning algorithms are being integrated into real-time monitoring systems, allowing predictive maintenance and adaptive process control to maximize yield and efficiency.

What Are the Key Market Drivers?

The growing demand for biologic drugs, gene therapies, and cell-based vaccines is a primary driver for the mammalian cell fermentation market. Governments and regulatory agencies are supporting biologic manufacturing expansion through fast-track approvals and funding for pandemic preparedness. The rise of biosimilars and next-generation antibody therapies is also fueling the need for cost-effective and scalable mammalian cell culture technologies.

Additionally, advancements in personalized medicine are increasing the demand for customized cell lines tailored to individual patients. The contract development and manufacturing organization sector is witnessing significant growth as pharmaceutical companies outsource mammalian cell fermentation to specialized providers to reduce costs and accelerate time to market. The increasing focus on sustainability in biomanufacturing is also leading to the adoption of environmentally friendly cell culture media and energy-efficient fermentation technologies.

What Challenges and Future Opportunities Exist?

Challenges in mammalian cell fermentation include high production costs, complex regulatory requirements, and scalability limitations in traditional batch processes. Maintaining cell viability and optimizing growth conditions remain significant technical hurdles. However, emerging innovations in continuous perfusion bioreactors, artificial intelligence-assisted cell culture optimization, and hybrid fermentation models are opening new opportunities for cost-effective and high-yield biopharmaceutical production.

The increasing adoption of personalized cell therapies, artificial intelligence-driven process automation, and modular biomanufacturing facilities is expected to shape the future of mammalian cell fermentation technology.

SCOPE OF STUDY:

The report analyzes the Mammalian Cell Fermentation Technology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types); Application (Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application, Hormones Application, Enzymes Application, Other Applications); End-Use (Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • AGC Biologics
  • Amgen Inc.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Moderna, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Samsung Biologics
  • Sartorius AG
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Mammalian Cell Fermentation Technology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expanding Biologics and Monoclonal Antibody Pipelines Propel Demand for Mammalian Cell Fermentation Platforms
    • Rising Adoption of CHO Cell Lines as the Industry Standard Enhances Production Consistency and Yield
    • Growing Shift Toward Personalized Medicine Drives Need for Flexible and Scalable Fermentation Solutions
    • Advancements in Bioreactor Design and Perfusion Technologies Improve Cell Viability and Throughput
    • Increased Use of Single-Use Bioprocessing Systems Enhances Operational Efficiency and Contamination Control
    • Regulatory Focus on cGMP Compliance Strengthens Investment in Quality-Controlled Fermentation Facilities
    • Expansion of Contract Manufacturing Organizations (CMOs) Boosts Outsourcing of Cell-Based Production
    • Emerging Markets in Asia and Latin America Drive Infrastructure Investments in Biomanufacturing
    • Rising Demand for Biosimilars Spurs Cost-Effective Cell Line Development and Process Optimization
    • AI-Driven Process Monitoring and Predictive Analytics Enhance Batch Quality and Scalability
    • High Cell Productivity Requirements Drive Innovation in Media Formulation and Feed Strategies
    • Growing Role of Mammalian Systems in Vaccine Production Expands Use in Infectious Disease Management
    • Increased Interest in Cell-Based Meat and Cultured Dairy Opens New Applications for Fermentation Tech
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mammalian Cell Fermentation Technology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mammalian Cell Fermentation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mammalian Cell Fermentation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chinese Hamster Ovary Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chinese Hamster Ovary Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Chinese Hamster Ovary Cell Fermentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Human Embryonic Kidney Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Human Embryonic Kidney Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Human Embryonic Kidney Cell Fermentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Baby Hamster Kidney Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Baby Hamster Kidney Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Baby Hamster Kidney Cell Fermentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Murine Myeloma Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Murine Myeloma Cell Fermentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Murine Myeloma Cell Fermentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Enzymes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Monoclonal Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Monoclonal Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Monoclonal Antibodies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Recombinant Proteins Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Recombinant Proteins Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Recombinant Proteins Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hormones Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Academic & Research Institutes End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Academic & Research Institutes End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Mammalian Cell Fermentation Technology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 179: India Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Mammalian Cell Fermentation Technology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Mammalian Cell Fermentation Technology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Mammalian Cell Fermentation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Mammalian Cell Fermentation Technology by Type - Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Mammalian Cell Fermentation Technology by Type - Percentage Breakdown of Value Sales for Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Mammalian Cell Fermentation Technology by Application - Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Mammalian Cell Fermentation Technology by Application - Percentage Breakdown of Value Sales for Enzymes Application, Other Applications, Monoclonal Antibodies Application, Recombinant Proteins Application, Vaccines Application and Hormones Application for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Mammalian Cell Fermentation Technology by End-Use - Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Mammalian Cell Fermentation Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Academic & Research Institutes End-Uses and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제